Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients

The aim of this study is to investigate the potential biomarkers associated with chronic myeloid leukemia (CML), reveal the metabolite changes related to the continuous phases of tyrosine kinase inhibitors (TKIs), and find the potential biomarkers associated with treatment effects. Fifty‐two patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bingyu, Wang, Chang, Xie, Yiyu, Xu, Liangjing, Wu, Xiaojin, Wu, Depei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834806/
https://www.ncbi.nlm.nih.gov/pubmed/29316075
http://dx.doi.org/10.1111/cas.13500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834806/
https://www.ncbi.nlm.nih.gov/pubmed/29316075
http://dx.doi.org/10.1111/cas.13500

Ejemplares similares